You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

locally advanced, unresectable breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Tumors Trial in La Jolla (Cirmtuzumab + Paclitaxel)

Active, not recruiting
  • Breast Neoplasms
  • Cirmtuzumab + Paclitaxel
  • La Jolla, California
    University of California, San Diego
May 16, 2022

Metastatic or Locally-advanced Unresectable Breast Cancer Trial in New York (BYL719, Letrozole, Exemestane)

Completed
  • Metastatic or Locally-advanced Unresectable Breast Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 1, 2022

Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer Trial in Shanghai (BL-B01D1, SI-B003)

Not yet recruiting
  • Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 12, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)

Recruiting
  • Metastatic Breast Cancer
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 26, 2023

Metastatic Breast Cancer Trial (SKB264, Eribulin, Capecitabine)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Oct 7, 2023

Breast Cancer Trial (RO7247669, Pembrolizumab, Nab-Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
May 2, 2023

Breast Cancer Trial (Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F

Not yet recruiting
  • Breast Cancer
  • Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates for Injection (FS-1502)
  • Control drug: Trastuzumab emtansine (Kadcyla, T-DM1)
  • (no location specified)
Feb 22, 2023

Human Epidermal Growth Factor Receptor 2-Positive Unresectable

Active, not recruiting
  • Metastatic Breast Cancer
  • Locally Advanced Breast Cancer
    • Athens, Greece
    • +1 more
    Jun 20, 2022

    Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

    Not yet recruiting
    • Metastatic Triple-Negative Breast Cancer
    • Charlotte, North Carolina
      Levine Cancer Institute
    Aug 31, 2023

    Breast Tumors Trial in Beijing, Nanjing, Changsha (Disitamab Vedotin, Toripalimab)

    Not yet recruiting
    • Breast Neoplasms
    • Beijing, Cancer Hospital Chinese Academy Of Medical Sciences, China
    • +2 more
    Oct 23, 2023

    Breast Cancer, Solid Tumor Trial in Shanghai (BL-B01D1)

    Recruiting
    • Breast Cancer
    • Solid Tumor
    • Shanghai, Shanghai, China
      Fudan University Cancer Hospital
    Jul 20, 2022

    Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Brussels, Barcelona, Madrid (JK08)

    Recruiting
    • Cancer
    • +6 more
    • Brussels, Belgium
    • +3 more
    Jan 30, 2023

    TNBC Trial in Shanghai (PM8002, nab-paclitaxel)

    Recruiting
    • TNBC
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Jun 25, 2023

    Breast Cancer Trial (Tucatinib, Eribulin, Trastuzumab)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    Jul 12, 2022

    HER2-positive Breast Cancer Trial (DP303c)

    Not yet recruiting
    • HER2-positive Breast Cancer
    • (no location specified)
    Apr 13, 2022

    Triple-Negative Breast Cancer Trial in Shanghai (Camrelizumab plus Famitinib with/without nab-Palitaxel)

    Not yet recruiting
    • Triple-Negative Breast Cancer
    • Camrelizumab plus Famitinib with/without nab-Palitaxel
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center Shanghai, China, 200032
    Jan 2, 2023

    Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Unresectable Breast Carcinoma Trial in Aurora (Nab-paclitaxel,

    Withdrawn
    • Triple Negative Breast Cancer
    • +4 more
    • Aurora, Colorado
      University of Colorado Hospital
    Dec 2, 2022

    Triple Negative Breast Cancer Trial (SKB264)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • (no location specified)
    Apr 20, 2022

    HER2-negative Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer Trial in Spain (Olaparib)

    Recruiting
    • HER2-negative Breast Cancer
    • +2 more
    • Barcelona, Spain
    • +4 more
    Apr 14, 2022

    Breast Cancer Trial (Injection of A166)

    Not yet recruiting
    • Breast Cancer
    • Injection of A166
    • (no location specified)
    Apr 20, 2022

    Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Marietta, East Brunswick (Sacituzumab

    Recruiting
    • Locally Advanced or Unresectable Metastatic Breast Cancer
    • Stage IV Breast Cancer
    • Sacituzumab Govitecan-hziy
    • +3 more
    • Marietta, Georgia
    • +1 more
    Apr 21, 2023

    Triple-Negative Breast Cancer Trial in Shanghai (camrelizumab in combination with nab-paclitaxel and famitinib)

    Active, not recruiting
    • Triple-Negative Breast Cancer
    • camrelizumab in combination with nab-paclitaxel and famitinib
    • Shanghai, China
      Zhi-Ming Shao
    Jan 7, 2022

    Triple-negative Breast Cancer Trial in Changsha, Nanjing (SKB264, KL-A167)

    Not yet recruiting
    • Triple-negative Breast Cancer
    • Changsha, Hunan, China
    • +1 more
    Jun 30, 2022

    Breast Cancer Trial in Worldwide (Ipatasertib, Placebo, Palbociclib)

    Active, not recruiting
    • Breast Cancer
    • Atlanta, Georgia
    • +19 more
    Dec 5, 2022

    Breast Cancer Stage IV, Unresectable Locally Advanced Invasive Breast Cancer, Metastatic Invasive Breast Cancer Trial in Boston

    Completed
    Has Results
    • Breast Cancer Stage IV
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Oct 21, 2022